Company Filing History:
1 out of 2,968 
1 out of 832,880 Years Active: 2001-2003
Title: Alexander Aristarkov: Innovator in Ubiquitin Carrier Polypeptides
Introduction
Alexander Aristarkov is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of ubiquitin carrier polypeptides. With a total of 2 patents, his work has implications for understanding cellular processes and potential therapeutic applications.
Latest Patents
Aristarkov's latest patents focus on cyclin-selective ubiquitin carrier polypeptides. These patents disclose novel human and clam ubiquitin carrier polypeptides that are involved in the ubiquitination of cyclins A and/or B. Additionally, the patents describe inhibitors of such polypeptides, nucleic acids encoding these polypeptides and inhibitors, antibodies specific for these polypeptides, and methods of their use. This innovative work has the potential to advance the understanding of cell cycle regulation and its associated disorders.
Career Highlights
Throughout his career, Aristarkov has worked with prestigious institutions, including Harvard College. His research has contributed to the advancement of knowledge in his field, and his patents reflect his commitment to innovation and scientific discovery.
Collaborations
Some of his notable coworkers include Joan V Ruderman and Avram Hershko. Their collaborative efforts have likely enriched the research environment and fostered significant advancements in their shared field of study.
Conclusion
Alexander Aristarkov's contributions to the field of biotechnology through his patents on ubiquitin carrier polypeptides highlight his role as an innovator. His work not only enhances scientific understanding but also opens avenues for future research and therapeutic development.